Very late recurrences of leukemia: Why does leukemia awake after many years of dormancy? (Q85245976)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Very late recurrences of leukemia: why does leukemia awake after many years of dormancy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Very late recurrences of leukemia: Why does leukemia awake after many years of dormancy? (English)

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

8 August 2024

author name string

Maxim Norkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Joseph P. Uberti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970853

8 August 2024

Charles A. Schiffer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20970853

8 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20970853

8 August 2024

publication date

1 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 February 2020

https://api.elsevier.com/content/article/PII:S0145212610004649?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

https://api.elsevier.com/content/article/PII:S0145212610004649?httpAccept=text/plain

8 August 2024

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

8 August 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

139-144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

Local Recurrences Following Mastectomy: Support for the Concept of Tumor Dormancy

16 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Cancer dormancy: opportunities for new therapeutic approaches

8 August 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X

8 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Late relapses after treatment for acute lymphoblastic leukemia in childhood: a population-based study from the Nordic countries

8 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP)

8 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Relapse after first cessation of therapy in childhood acute lymphoblastic leukemia: a 10-year follow-up study. Italian Association of Pediatric Hematology-Oncology (AIEOP)

8 August 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Very late recurrence of childhood acute lymphoblastic leukemia treated with chemoimmunotherapy: a report of three cases occurring 19, 11, and 9 years after discontinuation of chemotherapy

8 August 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Relapse of acute lymphoblastic leukaemia 14 years after presentation: use of molecular techniques to confirm true re-emergence

8 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Late recurrence of childhood acute lymphoblastic leukemia

8 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Lower leukocytes at initial diagnosis may predict poor outcome of very late relapse of acute lymphoblastic leukemia

8 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Outcome of very late relapse in children with acute lymphoblastic leukemia

8 August 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Long-term survival and late relapses in acute leukaemia in adults

8 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Two genetic hits (more or less) to cancer

8 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Chromosome translocations and covert leukemic clones are generated during normal fetal development

8 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic

8 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Molecular mechanisms underlying tumor dormancy

8 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Tumor dormancy in vivo by prevention of neovascularization

8 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.

8 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Leukaemic transformation of engrafted human marrow cells in vivo

8 August 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature

8 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Donor cell leukemia: insight into cancer stem cells and the stem cell niche

8 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Donor cell leukemia: a critical review

8 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

8 August 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Late relapses in acute myeloid leukemia: analysis of characteristics and outcome

8 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group (ECOG) experience

8 August 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Relapsed acute myelogenous leukemia occurring after 18 years with recurrent novel chromosomal abnormality t(18;22)(q23;q11.2)

8 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.

8 August 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase

8 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

8 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Blast crisis in a murine model of chronic myelogenous leukemia

8 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia

8 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation

8 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Loss of mismatched HLA in leukemia after stem-cell transplantation.

8 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Genetic trickery--escape of leukemia from immune attack

8 August 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia

8 August 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia

8 August 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

8 August 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.

8 August 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.09.016

8 August 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20970853%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference